NearWave

Oncology

Overview

NearWave is a new, non-invasive handheld imaging device for breast cancer that can change chemotherapy treatment to a potentially more effective one prior to surgery, or avoid 6-24 weeks of unnecessary therapy and move directly to surgery to improve outcomes and patient survival rates

Founder(s)

Roy Stillwell

Contact

rstillwell@nd.edu
Visit NearWave website